{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:11:39Z","timestamp":1789798299500,"version":"4.0.1"},"reference-count":213,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers in the world, with surgery, radiotherapy, chemotherapy, and immunotherapy being the primary treatment modalities. The treatment for HNSCC has evolved over time, due to which the prognosis has improved drastically. Despite the varied treatment options, major challenges persist. HNSCC chemotherapeutic and immunotherapeutic drugs are usually administered systemically, which could affect the patient\u2019s quality of life due to the associated side effects. Moreover, the systemic administration of salivary stimulating agents for the treatment of radiation-induced xerostomia is associated with toxicities. Localized drug delivery systems (LDDS) are gaining importance, as they have the potential to provide non-invasive, patient-friendly alternatives to cancer therapy with reduced dose-limiting toxicities. LDDSs involve directly delivering a drug to the tissue or organ affected by the disease. Some of the common localized routes of administration include the transdermal and transmucosal drug delivery system (DDSs). This review will attempt to explore the different treatment options using LDDSs for the treatment of HNSCC and radiotherapy-induced damage and their potential to provide a better experience for patients, as well as the obstacles that need to be addressed to render them successful.<\/jats:p>","DOI":"10.3390\/pharmaceutics15071844","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:49:47Z","timestamp":1687999787000},"page":"1844","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-2618","authenticated-orcid":false,"given":"Arvind","family":"Hariharan","sequence":"first","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dental Medicine and Oral Health Sciences, McGill University, 3640 University Street, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-359X","authenticated-orcid":false,"given":"Simon D.","family":"Tran","sequence":"additional","affiliation":[{"name":"McGill Craniofacial Tissue Engineering and Stem Cells Laboratory, Faculty of Dental Medicine and Oral Health Sciences, McGill University, 3640 University Street, Montreal, QC H3A 0C7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","unstructured":"Ferlay, J. (2023, June 11). Global Cancer Observatory: Cancer Today Lyon, France: International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/today."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.sdentj.2019.05.010","article-title":"Head and neck cancer management and cancer stem cells implication","volume":"31","author":"Elkashty","year":"2019","journal-title":"Saudi Dent. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Marcu, L.G., Dasu, I.T., and Dasu, A. (2015). The Six Rs of Head and Neck Cancer Radiotherapy, InTech.","DOI":"10.5772\/60015"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.coms.2018.09.003","article-title":"Current Concepts in Chemotherapy for Head and Neck Cancer","volume":"31","author":"Sindhu","year":"2019","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ctro.2021.11.007","article-title":"Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients","volume":"32","author":"Blanchard","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"European Organization for Research and Treatment of Cancer Trial 22931. Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"NEJM"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/1097-0142(19920115)69:2<285::AID-CNCR2820690203>3.0.CO;2-E","article-title":"Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma","volume":"69","author":"Urba","year":"1992","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncponc0750","article-title":"The chemoradiation paradigm in head and neck cancer","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"727433","DOI":"10.3389\/fonc.2021.727433","article-title":"Immunotherapy for Head and Neck Cancer: A Paradigm Shift from Induction Chemotherapy to Neoadjuvant Immunotherapy","volume":"11","author":"Shibata","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.oraloncology.2019.06.015","article-title":"Induction chemotherapy in head and neck cancers: Results and controversies","volume":"95","author":"Gau","year":"2019","journal-title":"Oral Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/annonc\/mdt461","article-title":"A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer","volume":"25","author":"Hitt","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized Trial of Induction Chemotherapy with Cisplatin and 5-Fluorouracil with or without Docetaxel for Larynx Preservation","volume":"101","author":"Pointreau","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.radonc.2015.10.014","article-title":"Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials","volume":"118","author":"Budach","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III Randomized Trial of Induction Chemotherapy in Patients with N2 or N3 Locally Advanced Head and Neck Cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and Radiation Therapy: Current Advances and Future Directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"ref_17","unstructured":"Dolan, J. (2009). Oral Radiology: Principles and Interpretation, Mosby Elsevier. [6th ed.]."},{"key":"ref_18","unstructured":"Koyfman, S.A. (2022, November 12). General Principles of Radiation Therapy for Head and Neck Cancer. Available online: https:\/\/www.uptodate.com\/contents\/general-principles-of-radiation-therapy-for-head-and-neck-cancer."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jasmer, K.J., Gilman, K.E., Mu\u00f1oz Forti, K., Weisman, G.A., and Limesand, K.H. (2020). Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions. J. Clin. Med., 9.","DOI":"10.3390\/jcm9124095"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","article-title":"Charged-particle therapy in cancer: Clinical uses and future perspectives","volume":"14","author":"Durante","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer\u2014A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0360-3016(00)01586-8","article-title":"Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence","volume":"50","author":"Schwartz","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archotol.129.9.944","article-title":"Treatment of Salivary Gland Neoplasms with Fast Neutron Radiotherapy","volume":"129","author":"Douglas","year":"2003","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.14338\/IJPT-20-00059.1","article-title":"Comparisons of 3-Dimensional Conformal and Intensity-Modulated Neutron Therapy for Head and Neck Cancers","volume":"8","author":"Viscariello","year":"2021","journal-title":"Int. J. Part. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/NCC.0000000000000194","article-title":"Use of Chamomilla recutita in the Prevention and Treatment of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized, Controlled, Phase II Clinical Trial","volume":"38","author":"Braga","year":"2015","journal-title":"Cancer Nurs."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1200\/JCO.2014.55.1945","article-title":"Promise and Pitfalls of Heavy-Particle Therapy","volume":"32","author":"Mitin","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/0022034518767408","article-title":"Localized Delivery of Amifostine Enhances Salivary Gland Radioprotection","volume":"97","author":"Varghese","year":"2018","journal-title":"J. Dent. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000502979","article-title":"Use of Amifostine for Cytoprotection during Radiation Therapy: A Review","volume":"98","author":"King","year":"2020","journal-title":"Oncology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","article-title":"Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector","volume":"12","author":"Kouvaris","year":"2007","journal-title":"Oncologist"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tran, S.D., Liu, Y., Xia, D., Maria, O.M., Khalili, S., Wang, R.W.-J., and Seuntjens, J. (2013). Paracrine Effects of Bone Marrow Soup Restore Organ Function, Regeneration, and Repair in Salivary Glands Damaged by Irradiation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061632"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103679","DOI":"10.1016\/j.critrevonc.2022.103679","article-title":"Immunotherapy for head and neck cancer: Present and future","volume":"174","author":"Fasano","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/fomm-21-48","article-title":"Immunotherapy in head and neck squamous cell carcinoma: A narrative review","volume":"4","author":"Sharon","year":"2022","journal-title":"Front. Oral Maxillofac. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/msb4100014","article-title":"A comprehensive pathway map of epidermal growth factor receptor signaling","volume":"1","author":"Oda","year":"2005","journal-title":"Mol. Syst. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_36","unstructured":"FDA (2021, June 11). Approves New Dosing Regimen for Cetuximab USA: U.S. Food and Drug Administration, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-new-dosing-regimen-cetuximab#:~:text=On%20April%206%2C%202021%2C%20the,the%20head%20and%20neck%20(SCCHN."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.annonc.2020.04.001","article-title":"Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study","volume":"31","author":"Ferris","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Veigas, F., Mahmoud, Y.D., Merlo, J., Rinflerch, A., Rabinovich, G.A., and Girotti, M.R. (2021). Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13051018"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1158\/0008-5472.CAN-18-1652","article-title":"Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma","volume":"78","author":"Baird","year":"2018","journal-title":"Cancer Res"},{"key":"ref_45","unstructured":"Jain, K.K. (2019). Drug Delivery Systems, Springer."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2011.02.008","article-title":"New developments and opportunities in oral mucosal drug delivery for local and systemic disease","volume":"64","author":"Hearnden","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_47","unstructured":"Christopher, R., Stephen, H., Ryan, G., and Paul, A.I. (2012). Current Concepts in General Thoracic Surgery, IntechOpen."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JDN.0b013e3182274a98","article-title":"Anatomy and Physiology of the Skin","volume":"3","author":"Kolarsick","year":"2011","journal-title":"J. Dermatol. Nurses\u2019 Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the Stratum Corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"ref_50","unstructured":"Mishra, D.K., Pandey, V., Maheshwari, R., Ghode, P., and Tekade, R.K. (2019). Basic Fundamentals of Drug Delivery, Academic Press."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s12274-020-2664-5","article-title":"Progress in transdermal drug delivery systems for cancer therapy","volume":"13","author":"Jiang","year":"2020","journal-title":"Nano Res."},{"key":"ref_52","first-page":"1","article-title":"Penetration enhancers: Role in transdermal drug delivery system","volume":"3","author":"Gupta","year":"2012","journal-title":"Pharm. Glob."},{"key":"ref_53","first-page":"495","article-title":"Transdermal gels\u2014An alternative vehicle for drug delivery","volume":"3","author":"Saroha","year":"2013","journal-title":"IJPCBS"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejpb.2015.02.015","article-title":"Transdermal delivery of testosterone","volume":"92","author":"Hadgraft","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.msec.2016.01.021","article-title":"Thermoresponsive polymeric gel as an on-demand transdermal drug delivery system for pain management","volume":"62","author":"Indulekha","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_56","first-page":"27","article-title":"Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea\/vomiting: Results of two pilot trials","volume":"6","author":"Bleicher","year":"2008","journal-title":"J. Support. Oncol."},{"key":"ref_57","first-page":"1218","article-title":"The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy","volume":"47","author":"Altun","year":"2018","journal-title":"Iran. J. Public Health"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients with Unresectable Squamous Cell Head and Neck Cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0885-3924(03)00146-5","article-title":"Analgesic Efficacy of Morphine Applied Topically to Painful Ulcers","volume":"25","author":"Zeppetella","year":"2003","journal-title":"J. Pain Symptom Manag."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.anl.2014.05.016","article-title":"Topical morphine gel for pain management in head and neck cancer patients","volume":"41","author":"Miyazaki","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/aoms.2018.72566","article-title":"Topical morphine for treatment of cancer-related painful mucosal and cutaneous lesions: A double-blind, placebo-controlled cross-over clinical trial","volume":"15","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_62","unstructured":"Abdalla-Aslan, R.W.H., and Elad, S. (2022). Orofacial Supportive Care in Cancer, Springer Nature."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_64","first-page":"1105","article-title":"Cancer treatment-induced oral mucositis","volume":"27","author":"Alterio","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2005.07.301","article-title":"Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: Final results of a phase II study","volume":"64","author":"Alterio","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ijrobp.2019.04.031","article-title":"Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel","volume":"104","author":"Liu","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20130490","DOI":"10.1259\/bjr.20130490","article-title":"Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: A pilot study","volume":"87","author":"Palatty","year":"2014","journal-title":"Br. J. Radiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1158\/1078-0432.CCR-05-0958","article-title":"Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse Model","volume":"11","author":"Cotrim","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1158\/1078-0432.CCR-07-0662","article-title":"Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging","volume":"13","author":"Cotrim","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4103\/ijdr.IJDR_138_20","article-title":"Prevention of dental caries by regular overnight application of a low-concentration fluoride gel loaded in a custom tray in patients undergoing radiotherapy for head and neck cancer: A preliminary study","volume":"31","author":"Yanamoto","year":"2020","journal-title":"Indian J. Dent. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/00220345770560022101","article-title":"Prevention of Xerostomia-Related Dental Caries in Irradiated Cancer Patients","volume":"56","author":"Dreizen","year":"1977","journal-title":"J. Dent. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1079-2104(96)80351-9","article-title":"Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer","volume":"82","author":"Epstein","year":"1996","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00520-019-05132-1","article-title":"Alleviation of dry mouth by saliva substitutes improved swallowing ability and clinical nutritional status of post-radiotherapy head and neck cancer patients: A randomized controlled trial","volume":"28","author":"Nuchit","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/bph.13059","article-title":"Transdermal patches: History, development and pharmacology","volume":"172","author":"Pastore","year":"2015","journal-title":"Br. J. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2478\/acph-2019-0016","article-title":"Transdermal patches: Design and current approaches to painless drug delivery","volume":"69","author":"Khan","year":"2019","journal-title":"Acta Pharm."},{"key":"ref_76","first-page":"26","article-title":"Transdermal patches: A recent approch to new drug delivery system","volume":"3","author":"Dhiman","year":"2011","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/JPR.S140320","article-title":"Transdermal buprenorphine and fentanyl patches in cancer pain: A network systematic review","volume":"10","author":"Ahn","year":"2017","journal-title":"J. Pain Res."},{"key":"ref_78","first-page":"CD010270","article-title":"Transdermal fentanyl for cancer pain","volume":"10","author":"Hadley","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/2049463717736787","article-title":"The use of fentanyl in pain management in head and neck cancer patients: A narrative review","volume":"12","author":"Giusti","year":"2017","journal-title":"Br. J. Pain"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jjco\/hyp166","article-title":"Transdermal Fentanyl for Pain Caused by Radiotherapy in Head and Neck Cancer Patients Treated in an Outpatient Setting: A Multicenter Trial in Taiwan","volume":"40","author":"Chang","year":"2009","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/DDDT.S60187","article-title":"Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: Evaluating efficacy, safety, and improvement in quality of life","volume":"8","author":"He","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/idj.12181","article-title":"Pain management during radiotherapy and radiochemotherapy in oropharyngeal cancer patients: Single-institution experience","volume":"65","author":"Zabrocka","year":"2015","journal-title":"Int. Dent. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2016.06.025","article-title":"Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer","volume":"65","author":"Haumann","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jphp.12334","article-title":"Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: A review","volume":"67","author":"Herman","year":"2015","journal-title":"J. Pharm. Pharm."},{"key":"ref_86","first-page":"3293","article-title":"Cytotoxic Activity of Essential Oils from Labiatae and Lauraceae Families Against In Vitro Human Tumor Models","volume":"27","author":"Loizzo","year":"2007","journal-title":"Anticancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","article-title":"Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.08.013","article-title":"Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin","volume":"182","author":"Zou","year":"2018","journal-title":"Biomaterials"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","article-title":"Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer","volume":"30","author":"Malam","year":"2009","journal-title":"Trends Pharm. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0959-8049(01)00216-7","article-title":"Phase II study of pegylated liposomal doxorubicin (Caelyx\u2122) as induction chemotherapy for patients with squamous cell cancer of the head and neck","volume":"37","author":"Harrington","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nucmedbio.2009.02.004","article-title":"[186Re] Liposomal doxorubicin (Doxil): In vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model","volume":"36","author":"Soundararajan","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.carbpol.2017.05.045","article-title":"Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment","volume":"173","author":"Anirudhan","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2217\/nnm-2018-0398","article-title":"Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carriers for the treatment of melanoma through transdermal delivery","volume":"14","author":"Ma","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","article-title":"Recent advances in transdermal drug delivery systems: A review","volume":"25","author":"Jeong","year":"2021","journal-title":"Biomater. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CCO.0000000000000828","article-title":"Nanoparticle therapy for head and neck cancers","volume":"34","author":"Hoffmann","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2147\/IJN.S301182","article-title":"NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models","volume":"16","author":"Zhang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07357907.2016.1213275","article-title":"A Phase I\/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab with Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck","volume":"35","author":"Chun","year":"2017","journal-title":"Cancer Investig."},{"key":"ref_99","first-page":"8977","article-title":"Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice","volume":"63","author":"Nishiyama","year":"2003","journal-title":"Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ces.2005.06.019","article-title":"Inorganic nanoparticles as carriers for efficient cellular delivery","volume":"61","author":"Xu","year":"2006","journal-title":"Chem. Eng. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"15027","DOI":"10.1073\/pnas.0404806101","article-title":"A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles","volume":"101","author":"Zhao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/cancers3032888","article-title":"Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications","volume":"3","author":"Mousa","year":"2011","journal-title":"Cancers"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41578-020-00277-6","article-title":"Extracellular vesicles versus synthetic nanoparticles for drug delivery","volume":"6","author":"Witwer","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1039\/C4CC08746A","article-title":"Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy","volume":"51","author":"Kong","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for topical drug delivery: Potential for skin cancer treatment","volume":"15","author":"Krishnan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for Cancer Therapy: Current Progress and Challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","article-title":"Enhancement strategies for transdermal drug delivery systems: Current trends and applications","volume":"12","author":"Ramadon","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Karpi\u0144ski, T.M. (2018). Selected Medicines Used in Iontophoresis. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10040204"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2018.05.038","article-title":"Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection","volume":"283","author":"Petrilli","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijpharm.2013.10.053","article-title":"Targeted local simultaneous iontophoresis of chemotherapeutics for topical therapy of head and neck cancers","volume":"460","author":"Gratieri","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.ijbiomac.2019.11.001","article-title":"Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: Iontophoresis further enhances drug delivery ex vivo","volume":"154","author":"Matos","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OTT.S238126","article-title":"Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer","volume":"13","author":"Ma","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmhi.2014.07.001","article-title":"Transdermal bFGF delivery using low-frequency sonophoresis: An innovative potential therapy for osteoradionecrosis of jaws","volume":"9","author":"Zhou","year":"2015","journal-title":"J. Med. Hypotheses Ideas"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/lio2.233","article-title":"Calcium electroporation for recurrent head and neck cancer: A clinical phase I study","volume":"4","author":"Plaschke","year":"2019","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Pisani, S., Bertino, G., Prina-Mello, A., Locati, L.D., Mauramati, S., Genta, I., Dorati, R., Conti, B., and Benazzo, M. (2022). Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination. Cancers, 14.","DOI":"10.3390\/cancers14215363"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/02656736.2021.1898683","article-title":"A preliminary study on ultrasound-guided percutaneous microwave ablation for palliative treatment of advanced head and neck malignancies","volume":"38","author":"Liao","year":"2021","journal-title":"Int. J. Hyperth."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1016\/j.biomaterials.2011.06.039","article-title":"Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer","volume":"32","author":"Melancon","year":"2011","journal-title":"Biomaterials"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mattod.2021.03.012","article-title":"Stimuli-responsive transdermal microneedle patches","volume":"47","author":"Makvandi","year":"2021","journal-title":"Mater. Today"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"33060","DOI":"10.1021\/acsami.8b12926","article-title":"Microneedle-Mediated Delivery of Lipid-Coated Cisplatin Nanoparticles for Efficient and Safe Cancer Therapy","volume":"10","author":"Lan","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"18885","DOI":"10.1039\/D0NR04213G","article-title":"Microneedles loaded with anti-PD-1\u2013cisplatin nanoparticles for synergistic cancer immuno-chemotherapy","volume":"12","author":"Lan","year":"2020","journal-title":"Nanoscale"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/1535-7163.MCT-21-0234","article-title":"Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs","volume":"21","author":"Gilardi","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2017.02.011","article-title":"Successful application of large microneedle patches by human volunteers","volume":"521","author":"Ripolin","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.addr.2020.10.018","article-title":"Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic","volume":"160","author":"Lam","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2004.07.030","article-title":"Transmucosal macromolecular drug delivery","volume":"101","author":"Prego","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00520-014-2491-x","article-title":"Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain","volume":"23","author":"Mercadante","year":"2015","journal-title":"Support. Care Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1185\/03007990903336135","article-title":"A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: An open-label, randomised, crossover trial","volume":"25","author":"Mercadante","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_128","first-page":"425","article-title":"Nicotine Replacement Therapy: An Overview","volume":"10","author":"Wadgave","year":"2016","journal-title":"Int. J. Health Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10689-010-9344-7","article-title":"Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer","volume":"9","author":"Suijkerbuijk","year":"2010","journal-title":"Fam. Cancer"},{"key":"ref_130","first-page":"1783","article-title":"Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal Women","volume":"85","author":"Downs","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.juro.2018.04.050","article-title":"Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials","volume":"200","author":"Kaminetsky","year":"2018","journal-title":"J. Urol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2147\/JPR.S192308","article-title":"Rectal enema of bupivacaine in cancer patients with tenesmus pain\u2014Case series","volume":"12","author":"Kowalski","year":"2019","journal-title":"J. Pain Res."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Rathi, R., Kumar, A., Vishvakarma, V., Huanbutta, K., Singh, I., and Sangnim, T. (2022). Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102210"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CPP48138","article-title":"Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/17425240902939135","article-title":"PecSys: In situ gelling system for optimised nasal drug delivery","volume":"6","author":"Watts","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12094-016-1570-5","article-title":"Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy","volume":"19","author":"Mazzola","year":"2017","journal-title":"Clin. Transl. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15171\/apb.2019.023","article-title":"Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting","volume":"9","author":"Garg","year":"2019","journal-title":"Adv. Pharm. Bull."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s11095-013-1029-0","article-title":"Docetaxel-Loaded Thermosensitive and Bioadhesive Nanomicelles as a Rectal Drug Delivery System for Enhanced Chemotherapeutic Effect","volume":"30","author":"Seo","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.jddst.2020.101669","article-title":"5-aminopyrazole-conjugated gelatin hydrogel: A controlled 5-fluorouracil delivery system for rectal administration","volume":"57","author":"Nazeri","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40880-016-0097-z","article-title":"Effect of preoperative injection of carbon nanoparticle suspension on the outcomes of selected patients with mid-low rectal cancer","volume":"35","author":"Zhang","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1163\/092050611X560861","article-title":"A Novel In-Situ-Gelling Liquid Suppository for Site-Targeting Delivery of Anti-Colorectal Cancer Drugs","volume":"23","author":"Lin","year":"2012","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_143","unstructured":"Sattar, M., and Lane, M.E. (2021). Drug Delivery Approaches: Perspectives from Pharmacokinetics and Pharmacodynamics, Wiley."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1601-0825.2011.01793.x","article-title":"Local drug delivery for oral mucosal diseases: Challenges and opportunities","volume":"17","author":"Sankar","year":"2011","journal-title":"Oral Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/22103031113039990011","article-title":"Transmucosal Drug Delivery\u2014An Overview","volume":"4","author":"Abhang","year":"2014","journal-title":"Drug Deliv. Lett."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S0022215100127768","article-title":"A comparison of artificial saliva and pilocarpine in radiation induced xerostomia","volume":"108","author":"Davies","year":"1994","journal-title":"J. Laryngol. Otol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1038\/bdj.2007.80","article-title":"A controlled release pilocarpine buccal insert in the treatment of Sj\u00f6gren\u2019s syndrome","volume":"202","author":"Gibson","year":"2007","journal-title":"Br. Dent. J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijbiomac.2019.05.219","article-title":"Buccal adhesive chitosan conjugate comprising pilocarpine for xerostomia","volume":"135","author":"Laffleur","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Muthumariappan, S., Ng, W.C., Adine, C., Ng, K.K., Davoodi, P., Wang, C.-H., and Ferreira, J.N. (2019). Localized Delivery of Pilocarpine to Hypofunctional Salivary Glands through Electrospun Nanofiber Mats: An Ex Vivo and In Vivo Study. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030541"},{"key":"ref_151","unstructured":"Helsinn Healthcare, S.A., and Latis, S.r.l. (2023, June 11). Effects of Aqualief\u00ae in Patients with Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03601962."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Iacovelli, N.A., Ingargiola, R., Facchinetti, N., Franceschini, M., Romanello, D.A., Bossi, P., Bergamini, C., Alfieri, S., Cavalieri, S., and Baron, G. (2021). A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia. Cancers, 13.","DOI":"10.3390\/cancers13143456"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"103660","DOI":"10.1016\/j.jddst.2022.103660","article-title":"Mucoadhesive buccal films for treatment of xerostomia prepared by coupling HME and 3D printing technologies","volume":"75","author":"Elkanayati","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_154","unstructured":"Access Pharmaceuticals, I. (2023, June 11). A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01283906."},{"key":"ref_155","unstructured":"Wake Forest University Health Sciences, Professional Compounding Centers of America (2023, June 11). MucoLox Formulation to Mitigate Mucositis Symptoms in Head\/Neck Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03461354."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/cncr.28553","article-title":"Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck","volume":"120","author":"Allison","year":"2014","journal-title":"Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/ajco.12295","article-title":"Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial","volume":"13","author":"Ghalayani","year":"2017","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"10091","DOI":"10.1200\/jco.2014.32.15_suppl.10091","article-title":"Effect of topical clonidine on the duration and severity of radiation-induced oral mucositis (OM) in a translational hamster model","volume":"32","author":"Attali","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2019.10.023","article-title":"Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated with Concomitant Chemoradiation Therapy for Head and Neck Cancer","volume":"106","author":"Giralt","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/odi.13749","article-title":"The effect of topical chamomile in the prevention of chemotherapy-induced oral mucositis: A randomized clinical trial","volume":"28","author":"Elhadad","year":"2022","journal-title":"Oral Dis."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Ketabat, F., Pundir, M., Mohabatpour, F., Lobanova, L., Koutsopoulos, S., Hadjiiski, L., Chen, X., Papagerakis, P., and Papagerakis, S. (2019). Controlled Drug Delivery Systems for Oral Cancer Treatment\u2014Current Status and Future Perspectives. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11070302"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/0022034518772278","article-title":"Head and Neck Cancer in the New Era of Precision Medicine","volume":"97","author":"Gutkind","year":"2018","journal-title":"J. Dent. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_164","first-page":"135","article-title":"NCCN Practice Guidelines for Cancer Pain","volume":"14","author":"Benedetti","year":"2000","journal-title":"Oncology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00561135","article-title":"Pharmacokinetics of fentanyl in man and the rabbit","volume":"4","author":"Hess","year":"1972","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"20586","DOI":"10.1200\/jco.2008.26.15_suppl.20586","article-title":"The safety of BEMA (BioErodible MucoAdhesive) Fentanyl for breakthrough pain (BTP) in cancer patients","volume":"26","author":"Blum","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Kapourani, A., Kontogiannopoulos, K.N., and Barmpalexis, P. (2022). A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development. Pharmaceuticals, 15.","DOI":"10.3390\/ph15060762"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Mura, P., Maestrelli, F., Cirri, M., and Mennini, N. (2022). Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review. Mar. Drugs, 20.","DOI":"10.3390\/md20050335"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"ref_170","first-page":"39","article-title":"Role of cisplatin in oral squamous cell carcinoma\u2014A review","volume":"7","author":"Marimuthu","year":"2017","journal-title":"J. Adv. Pharm. Educ. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/cas.12079","article-title":"Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma","volume":"104","author":"Endo","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1038\/s41467-022-31859-3","article-title":"A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer","volume":"13","author":"Goldberg","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2005.07.035","article-title":"Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles","volume":"239","author":"Elsayed","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.7150\/thno.15088","article-title":"In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers","volume":"6","author":"Lucky","year":"2016","journal-title":"Theranostics"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.colsurfb.2018.09.076","article-title":"Delivery of MTH1 inhibitor (TH287) and MDR1 siRNA via hyaluronic acid-based mesoporous silica nanoparticles for oral cancers treatment","volume":"173","author":"Shi","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.3390\/cimb44110357","article-title":"Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5","volume":"44","author":"Sharifi","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"101046","DOI":"10.1016\/j.nantod.2020.101046","article-title":"Polymers and inorganic nanoparticles: A winning combination towards assembled nanostructures for cancer imaging and therapy","volume":"36","author":"Yang","year":"2021","journal-title":"Nano Today"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Ruiz-Pulido, G., Medina, D.I., Barani, M., Rahdar, A., Sargazi, G., Baino, F., and Pandey, S. (2021). Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review. Materials, 14.","DOI":"10.3390\/ma14133706"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bioactmat.2022.08.010","article-title":"Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review","volume":"25","author":"Yu","year":"2023","journal-title":"Bioact. Mater."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcis.2011.12.063","article-title":"Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications","volume":"370","author":"Mazzarino","year":"2012","journal-title":"J. Colloid Interface Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1166\/jnn.2015.9189","article-title":"Curcumin-Loaded Chitosan-Coated Nanoparticles as a New Approach for the Local Treatment of Oral Cavity Cancer","volume":"15","author":"Mazzarino","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.colsurfb.2013.03.039","article-title":"Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB)","volume":"110","author":"Arulmozhi","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03639040701484593","article-title":"PLGA Nanoparticles for the Oral Delivery of 5-Fluorouracil Using High Pressure Homogenization-Emulsification as the Preparation Method and In Vitro\/In Vivo Studies","volume":"34","author":"Li","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"24629","DOI":"10.1038\/srep24629","article-title":"Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.2147\/IJN.S215087","article-title":"CD44-Targeted Magnetic Nanoparticles Kill Head and Neck Squamous Cell Carcinoma Stem Cells in An Alternating Magnetic Field","volume":"14","author":"Su","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_187","first-page":"350","article-title":"Novel drug delivery system based on hollow mesoporous magnetic nanoparticles for head and neck cancers--targeted therapy in vitro and in vivo","volume":"10","author":"Zhang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/IJN.S150610","article-title":"Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment","volume":"13","author":"Wang","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/acs.molpharmaceut.0c00706","article-title":"Correction to \u201cEnhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade\u201d","volume":"17","author":"Satapathy","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1021\/acs.molpharmaceut.0c00716","article-title":"Correction to \u201cComparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer\u201d","volume":"17","author":"Hembram","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: Promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221013804484827","article-title":"Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting","volume":"7","author":"Fang","year":"2013","journal-title":"Recent Pat Nanotechnol."},{"key":"ref_193","first-page":"321","article-title":"Cytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell lines","volume":"27","author":"Iida","year":"2013","journal-title":"In Vivo"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10717544.2016.1236849","article-title":"Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer","volume":"24","author":"Yang","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nmeth.3839","article-title":"A practical guide to hydrogels for cell culture","volume":"13","author":"Caliari","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e2100039","DOI":"10.1002\/mabi.202100039","article-title":"Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune-Based Combination Therapy","volume":"21","author":"Ma","year":"2021","journal-title":"Macromol. Biosci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.tibtech.2017.06.015","article-title":"Engineered Hydrogels in Cancer Therapy and Diagnosis","volume":"35","author":"Sepantafar","year":"2017","journal-title":"Trends Biotechnol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1039\/C7PY00112F","article-title":"Improving tumor chemotherapy effect using an injectable self-healing hydrogel as drug carrier","volume":"8","author":"Yang","year":"2017","journal-title":"Polym. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.biomaterials.2016.02.001","article-title":"Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot","volume":"85","author":"Kim","year":"2016","journal-title":"Biomaterials"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Ran, B., Xie, X., Gu, W., Ye, X., and Liao, J. (2022). Developments on the Smart Hydrogel-Based Drug Delivery System for Oral Tumor Therapy. Gels, 8.","DOI":"10.3390\/gels8110741"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Li, J., Gong, C., Feng, X., Zhou, X., Xu, X., Xie, L., Wang, R., Zhang, D., Wang, H., and Deng, P. (2012). Biodegradable Thermosensitive Hydrogel for SAHA and DDP Delivery: Therapeutic Effects on Oral Squamous Cell Carcinoma Xenografts. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033860"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"17168","DOI":"10.1039\/D1NR04625J","article-title":"Near-infrared light-responsive hybrid hydrogels for the synergistic chemo-photothermal therapy of oral cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Nanoscale"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"31264","DOI":"10.1039\/C9RA04343H","article-title":"MMP-responsive in situ forming hydrogel loaded with doxorubicin-encapsulated biodegradable micelles for local chemotherapy of oral squamous cell carcinoma","volume":"9","author":"Li","year":"2019","journal-title":"RSC Adv."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2147\/IJN.S191069","article-title":"The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy for head and neck squamous cell carcinoma","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Teng, Y., Gao, L., Loveless, R., Rodrigo, J.P., Strojan, P., Willems, S.M., Nathan, C.-A., M\u00e4kitie, A.A., Saba, N.F., and Ferlito, A. (2021). The Hidden Link of Exosomes to Head and Neck Cancer. Cancers, 13.","DOI":"10.3390\/cancers13225802"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-020-01278-3","article-title":"Exosome-based immunotherapy: A promising approach for cancer treatment","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12951-018-0403-9","article-title":"Recent advancements in the use of exosomes as drug delivery systems","volume":"16","author":"Bunggulawa","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Khayambashi, P., Iyer, J., Pillai, S., Upadhyay, A., Zhang, Y., and Tran, S.D. (2021). Hydrogel Encapsulation of Mesenchymal Stem Cells and Their Derived Exosomes for Tissue Engineering. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020684"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1039\/D0BM01735C","article-title":"\u2018Golden\u2019 exosomes as delivery vehicles to target tumors and overcome intratumoral barriers: In vivo tracking in a model for head and neck cancer","volume":"9","author":"Cohen","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"TPS633","DOI":"10.1200\/JCO.2022.40.4_suppl.TPS633","article-title":"Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation","volume":"40","author":"Surana","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_213","unstructured":"Khayambashi, P. (2022). Mesenchymal Stem Cell Exosomes as a Cell-Free Therapy for Restoring Acinar Cell Signalling in Salivary Glands through the Induction of Wnt\/Beta-Catenin Pathway. [Master\u2019s Thesis, McGill University]."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/7\/1844\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:02:48Z","timestamp":1760126568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/7\/1844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":213,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["pharmaceutics15071844"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15071844","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}